Human Infection with Avian Influenza A(H7n9) Virus in Shanghai: Current Status and Future Trends
Shen Yinzhong,Lu Hongzhou
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20140399
IF: 6.133
2014-01-01
Chinese Medical Journal
Abstract:Avian influenza A(H7N9) virus is one subgroup among the larger group of H7 viruses, which normally circulate among birds. The H7N9 subtype of avian influenza viruses has not been known to infect humans until only recently. On March 31, 2013, China confirmed the first three human cases of novel avian influenza A(H7N9) infection in Shanghai and Anhui, two of these patients died.1 As of February 27, 2014, 367 laboratory-confirmed human cases have been reported from 15 provinces/municipalities in mainland China, the most (136) from China's Zhejiang province.2 H7N9 virus transmission and infection continue endash 127 confirmed human H7N9 cases were reported in January 2014.3 Temporal distribution of avian influenza A(H7N9) in China According to the World Health Organisation,4 a total of 133 human H7N9 cases occurred in an initial wave on infections from February through May 2013. Reports of H7N9 infection decreased during the summer (with only two reported cases), and increased again in October 2013, the onset of a second wave of human infection, likely in conjunction with cooler temperatures. The number of human cases of avian H7N9 influenza virus infection in the second wave now exceeds those in the first wave. It is unlikely that the number of cases will begin to decline before the end of the winter influenza season, and/or until there has been a comprehensive closure of live poultry markets. The H7N9 avian influenza death toll hit 31 in mainland of China in January 2014. The number is almost as high as for the whole of 2013, when China had 144 confirmed cases including 46 deaths.3 An updated risk assessment completed by the WHO (January 21, 2014) highlighted that the case fatality rate from wave 2 is not as high as the first wave of infections in the 2013.5 As of Jan uary 28,2014, the case fatality rate of all confirmed cases is 22%, but many cases are still hospitalized.4 This increasing number of new H7N9 cases and high mortality has caused global concern and worries of spread outside of China. Avian influenza A(H7N9) epidemic in Shanghai Since Shanghai reported the first case of human infection with H7N9 virus at the end of March 2013, a total of 33 laboratory-confirmed human cases have been reported in Shanghai in 2013; 18 patients (54.5%) died while 15 were discharged from hospital with full recovery.6 The majority of the Shanghai cases occurred between February and early April 2013. Reports of human infections in Shanghai decreased rapidly after closures of live poultry markets, starting April 6, 2013.7 No new cases were reported from May through December 2013. In 2014, Shanghai has reported eight cases, including four deaths.2,8 Shanghai's first H7N9 case of the 2013-2014 winter was reported on 4 January 2014, when an 86-year-old man who had bought live poultry in a market developed H7N9 infection.9 Six of 8 cases were males, with an age range from 31 to 86 years. All had exposure to poultry or a live poultry market but have been scattered throughout the city. Shanghai has temporarily suspended live poultry markets from January 31, 2014.8 Compared with other currently affected provinces, Shanghai has reported fewer H7N9 cases in the second wave, which may be associated with either enhanced public awareness of the virus and/or closures of live poultry markets. Current epidemiologic trends indicate that a large-scale H7N9 epidemic in Shanghai, or other regions of China is unlikely. However, influenza activity often increases during the winter and spring, and it is likely that sporadic H7N9 cases will continue in Shanghai in the future. H7N9 virus infection in health care workers is of specific interest because it indicates increased risk of human-to-human transmission. H7N9 virus infection was identified in a 31-year-old doctor who worked predominantly in a Shanghai hospital Emergency Room.9 He had fever for one week before his condition deteriorated on January 17, 2014, requiring hospital admission for intensive care and mechanical ventilation. Despite this support, he died on January 18, 2014. Public health investigations suggested possible exposure to poultry or a contaminated poultry market environment as the most likely source. No other associated cases have been identified. Two family clusters of cases of H7N9 virus infection had been identified in the first wave in Shanghai.10 According to the largest reported epidemiological study to date,10 while a few small clusters with possible human-to-human transmission among family members have occurred, there has been no evidence of sustained human-to-human transmission. Limited, nonsustained human-to-human H7N9 virus transmission cannot be ruled out. Information to date does not support sustained human-to-human transmission.5 Though the H7N9 virus doesn't appear to have the capacity for efficient human-to-human spread, new reassortants with seasonal influenza strains could confer the ability to transmit more easily, a situation that requires close monitoring. Avian influenza A(H7N9) experience in Shanghai Temporary closures of live poultry markets On April 4, 2013, avian influenza A(H7N9) virus was detected in pigeons at live poultry markets in Shanghai. The Shanghai government has closed all live poultry markets in Shanghai since April 6, 2013.7 After the closures, the number of newly infected cases declined rapidly, no new infections were found in Shanghai after April 13, 2013, and no new cases were reported after April 20, 2013. The ban was lifted in June 2013 after the city introduced new regulations to manage poultry markets. Shanghai reported the year's first H7N9 case on January 4, 2014. Shanghai has suspended live poultry markets from January 31, 2014 to prevent a recurrence of the H7N9 influenza.8 So far, Shanghai has reported only eight cases in 2014. The live poultry market closure strategy may had an impact on the reduction of virus transmission and elimination of successive large outbreaks. Many cities in China had also temporarily or permanently closed live poultry markets to prevent the spread of H7N9 virus infection.8 The definitive source of H7N9 virus infection is still unknown. Most cases have been reported to have a history of exposure to poultry or a live poultry market.10, 11 Therefore, the most likely source of infection is assumed to be direct or indirect contact with infected poultry or contaminated environments.5 However, some human cases reported have no obvious poultry exposure. A better understanding of exposures and subsequent transmission is important to reducing risk of further human infections. Case-control studies may identify or clarify certain risk factors for H7N9 virus infection. Such studies to date have not isolated specific high-risk behaviors or exposures, beyond a general exposure to poultry, live poultry markets, or contaminated environments.5 However, the move to close poultry markets appears necessary and effective in reducing the risk contact with infected live poultry. One study12 showed that closure of live poultry markets reduced the mean daily number of H7N9 infections by 99% in Shanghai, 99% in Hangzhou, 97% in Huzhou, and 97% in Nanjing. The authors suggested that live poultry market closure should be rapidly implemented in areas where the virus is identified. Although live poultry market closure in specific circumstances can eectively interrupt human exposure to avian influenza A(H7N9) virus, if applied in isolation, this measure is unlikely to eliminate the zoonotic threat.13 In addition, obtaining support for permanent closure of live poultry markets from the public might be difficult, particularly among younger adults and adults with lower educational attainment.14 Several steps have been taken to reduce the risk of transmission to humans in Shanghai. These include temporary closures of live poultry markets, improved hygiene in markets, heightened and ongoing surveillance in poultry and live poultry market environment, and control of poultry movement. Strict surveillance is a continuing requirement and a cross-sector effort will be needed to reduce H7N9's threat. Strengthening early diagnosis and antiviral treatment Early detection and antiviral treatment are essential in improving survival rates of H7N9 patients.15 An investigation reflected a significant delay in the diagnosis and antiviral treatment of H7N9 patients in the early stage of epidemic in Shanghai in 2013.16 A delayed diagnosis may be due to a weak knowledge among medical staff and the general public towards H7N9 virus associated diseases. This delay may compromise early management of patients with avian influenza A(H7N9). In order to strengthen early diagnosis and anitviral treatment, enhanced disease surveillance, health measures, and health education against avian influenza are ongoing in Shanghai. Prompt antiviral therapy with neuraminidase inhibitors appears to improve clinical outcomes. In Shanghai, empiric use of oseltamivir when clinically suspected was recommended to prevent severe cases and deaths. Human cases of H7N9 virus infection is the first time discovered and reported. Many reported cases10,11 have had a significant delay between the onset of symptoms, presentation, diagnosis and initiation of antiviral treatment; highlighting an area for both public and health care worker education. The understanding of this novel virus infection should be enhanced among the public and health care workers. According to the investigations conducted in China,10,11,16 influenza A(H7N9) virus infections can occur in both males and females, but most confirmed cases occurred in males. The majority of the patients had one or more underlying medical conditions. The prominent clinical features on admission were those of a severe influenza syndrome with fever, cough, fatigue, and shortness of breath. The most striking laboratory findings were marked lymphopenia and thrombocytopenia. According to the report5 from the WHO, most cases in the first wave have occurred in middle-aged or older men. The mean age is slightly lower in the second wave (52 versus 58 years) than in the first wave. Although milder cases have been reported, patients with H7N9 virus infection often experience rapidly progressing severe pneumonia. Atypical clinical presentation for avian influenza A(H7N9) has not been reported. Health care professionals should pay special attention to patients with the presentations listed above who might have had contact with poultry, birds, or their droppings. If H7N9 virus infection is suspected, oseltamivir treatment should be started as soon as possible. Suspected cases should be immediately referred to the fever clinics for follow-up investigation. It is important to continue to adher to the priniciple "early discovery, early reporting, early diagnosis and early treatment", this strategy will help futher reduce the mortality. Cross-sector and multidisciplinary cooperation The Shanghai government has played an important role in the control and prevention of H7N9 epidemic in Shanghai. The Shanghai authority has asked health departments at all levels to jointly prevent and control the virus, enhance communication with relevant national departments, and to further reinforce the monitoring and treatment of H7N9 virus infection. Novel reassortant H7N9 viruses are associated with severe and frequently fatal respiratory disease in humans. Nearly all patients diagnosed with H7N9 infection have been admitted to hospital and most have become critically ill.10,11 Patients with serious illness often deteriorate into acute respiratory distress syndrome (ARDS), sepsis, septic shock, and multiple organ failure. The case-fatality rate among those admitted to hospital is approximately 36%; lower than that for influenza A H5N1 (60%-65%), but higher than that for the 2009 influenza A H1N1 pandemic virus (21%).17 In addition to the primary viral respiratory illness, secondary bacterial infection is common and demands consideration of empiric antibacterial therapy for both undifferentiated pneumonia while awaiting diagnostic testing, and for patients with clinical deteriorations after clinically evident or proven primary influenza infections. The frequent occurrence of critical illness demands that hospitals and healthcare workers caring for these patients are well equipped to deliver multi-disciplinary intensive care to support not only respiratory failure, but the common concomitant cardiovascular failure and renal insufficiency that accompanies critical illness. The principle called "four antis and two balance" was used to treat H7N9 patients in Shanghai: antiviral therapy, anti-hypoxemia and multiple organ failure and multiple organ dysfunction syndrome, anti-shock therapy, anti-infective therapy; maintaining water and electrolyte acid-base balance, regulating the micro-ecological balance. The strategies emphasized on early antiviral treatment within 48 hours after the onset of the disease, active respiratory support, and prevention and treatment of multiple organ damage and complications, focus on strengthening the multidisciplinary treatment cooperation. Strengthening diagnosis and treatment capacity of medical facilities Medical facilities in Shanghai were asked to strengthen the training of medical personnel (especially physicians working in the fever clinics) on the knowledge of diagnosis and treatment, disinfection and isolation, and personal protection to improve management of human cases of H7N9 virus infection, especially severe cases. During the course of treatment of confirmed cases, doctors should identify patients with risk factors for severe influenza illness who should be closely monitored. Medical facilities at all levels should take measures to strengthen supervision over the quality of medical equipment used in the diagnosis and treatment of H7N9 virus infection and guarantee sufficient quantity and quality of prevention and control materials. A team of doctors with expertise in H7N9 treatment from local hospitals in Shanghai was set up to help manage the disease. Medical facilities that have limited pre-existing capacity to manage the severe H7N9 cases should take full advantage of the city's medical resources to help treatment of severe cases. Conclusion Current epidemiologic trends indicate that a large-scale H7N9 epidemic in Shanghai, or other regions of China is unlikely. However, it is likely that sporadic H7N9 cases will continue in Shanghai in the future. Though the H7N9 virus doesn't appear to have the capacity for efficient human-to-human spread, new reassortants with seasonal influenza strains could confer the ability to transmit more easily, a situation that requires close monitoring. The move to close poultry markets appears necessary and effective in reducing the risk contact with infected live poultry. Early diagnosis and antiviral treatment are essential in improving survival rates. Strict surveillance is a continuing requirement and a cross-sector effort will be needed to reduce H7N9's threat. Shanghai's experience could provide reference for other provinces in China and other countries to control and prevent human infection with avian influenza A (H7N9) virus. We need to learn more about the prevalence of H7N9 virus among animal reservoirs, specific animal-to-human modes of transmission, improve both public and healthcare professional response to suspected infection, and ensure hospitals institute prompt antiviral, antibacterial and supportive critical care. Acknowledgments: We acknowledge the review of this manuscript by Rob Fowler (World Health Organisation, Pandemic and Epidemic Diseases; and the University of Toronto, Toronto, Canada).